A comprehensive health system based in Wisconsin recently received $5 million in grant funds to boost critical research, medical education, and improved patient care. Gunderson…
OneOncology, the private equity-backed national platform for independent community oncology practices, announced two new Board of Managers and shared with TrialSite the robust clinical trials…
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it has initiated a pediatric expansion of its…
Exclusive to TrialSite News By Gerard Barron, Vice President of Operations, Illingworth Research Group, a Syneos Health Company “How Are Savvy Patients Becoming a Force…
By Jasmina Jankicevic, M.D., M.S., CCRP, Vice President, Medical Affairs, Dermatology and Medical Aesthetics, Premier Research Skin diseases are the fourth leading cause of health…
By Anthony Poynton, Senior Director, Program Delivery, Rare Disease & Pediatrics, Premier Research & Vicki Gashwiler, Executive Director, Specialty Programs, Premier Research In the year…
TrialSite’s coverage in the past year includes the ongoing research and development associated with France-based MedinCell, the biotech developing several long-acting injectable formulations of ivermectin.…
John W. Swanson, an 81-year-old farmer from Stafford, New York, a rural area east of Buffalo, was infected with COVID-19, on a ventilator, and according…
Article 1Texas Physician/Researchers Case Series Finds Reduction in COVID-19 Hospitalization by 87.6% & Death 74.9%: A group of Texas-based providers, including physicians, some highly published,…
CORRECTION: The following graphic replaces the graphic in the video at 5:44. Click here to view original article Dr. Ron Brown of Waterloo University talks…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
